{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Vimentin",
      "breast cancer tissues",
      "cytokeratin-18",
      "fibronectin-1",
      "laminin-1 receptor",
      "metastasis"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31601144",
  "DateCompleted": {
    "Year": "2020",
    "Month": "05",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "05",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "10",
        "Day": "11"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/0300060519877079"
    ],
    "Journal": {
      "ISSN": "1473-2300",
      "JournalIssue": {
        "Volume": "47",
        "Issue": "11",
        "PubDate": {
          "Year": "2019",
          "Month": "Nov"
        }
      },
      "Title": "The Journal of international medical research",
      "ISOAbbreviation": "J Int Med Res"
    },
    "ArticleTitle": "Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer.",
    "Pagination": {
      "StartPage": "5767",
      "EndPage": "5776",
      "MedlinePgn": "5767-5776"
    },
    "Abstract": {
      "AbstractText": [
        "This study investigated immunohistochemical staining results of two cytoskeletal proteins (vimentin and cytokeratin-18) and two extracellular matrix proteins (fibronectin-1 and laminin-1 receptor) in different stages of triple negative breast cancer.",
        "Forty triple negative cancerous breast tissues from patients diagnosed as stage 2A (15), 2B (nine), 3A (10), 3B (four), and 3C (two) were included in this study and were compared with 42 normal breast tissues. Immunohistochemistry results were statistically analyzed using the t-test percent of the StatPac program.",
        "The percentages of positive staining in cancerous tissues for all of the studied parameters were significantly greater than their percentages in normal tissues, except for vimentin. All cancerous tissues from patients diagnosed as stage 3A, 3B, and 3C were positive for both fibronectin-1 and laminin-1 receptor.",
        "Fibronectin-1 and laminin-1 receptor are promising markers for stage 3 triple negative breast cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-3909-3788"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departement of Chemistry, Faculty of Science, King Khalid University, Abha, Saudi Arabia."
          }
        ],
        "LastName": "Mohammed",
        "ForeName": "Mohammed Elimam Ahamed",
        "Initials": "MEA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sudan Atomic Energy Commission, Khartoum, Sudan."
          }
        ],
        "LastName": "Elhassan",
        "ForeName": "Nuha Mohammed",
        "Initials": "NM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Int Med Res",
    "NlmUniqueID": "0346411",
    "ISSNLinking": "0300-0605"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cytoskeletal Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Extracellular Matrix Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cytoskeletal Proteins"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Extracellular Matrix Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Metastasis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Staging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Odds Ratio"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Staining and Labeling"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Triple Negative Breast Neoplasms"
    }
  ]
}